IMPDH2 and sarcoma: Given that sarcomas are a rare and diverse group of malignancies with distinct molecular characteristics, future studies with larger and more homogeneous patient cohorts are necessary to clarify the prognostic value of IMPDH2 expression in sarcoma, and to determine its variability across different subtypes.